Prevalence and predictors of small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis
The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Abstract
Background The reported prevalence of small intestinal bacterial overgrowth (SIBO) among individuals with irritable bowel syndrome (IBS) is highly variable. The aim of the study is to estimate the prevalence and identify predictors of SIBO in IBS.Methods PubMed, Cochrane Library, and EMBASE through July 2017 were searched to identify studies evaluating the prevalence of SIBO in IBS. The pooled prevalence of SIBO among individuals with IBS and the pooled odds ratio (OR) of SIBO among those with IBS compared with healthy controls were calculated. Predictors of SIBO among IBS patients were also evaluated.Results Fifty studies (8398 IBS, 1432 controls) met the inclusion criteria. Overall pooled prevalence of SIBO in IBS was 38% (95% CI 32-44) and was higher among individuals with IBS (OR 4.7, 95% CI 3.1-7.2) compared with controls. The pooled prevalence of SIBO in IBS was higher in studies diagnosed by breath tests (40%, 95% CI 33-46) compared with cultures (19%, 95% CI 8-30). Among those with IBS, female gender (OR 1.5, 95% CI 1.0-2.1), older age (standard mean difference 3.1 years, 95% CI 0.9-5.4), and IBS-diarrhea (OR 1.7, 95% CI 1.3-2.3) compared with other IBS subtypes increased the odds of SIBO; proton pump inhibitor (PPI) use (OR 1.1, 95% CI 0.7-1.7) was not associated with SIBO.Conclusions More than one-third of IBS patients tested positive for SIBO, and the odds of SIBO in IBS were increased by nearly fivefold. The prevalence of SIBO varied according to the diagnostic modality performed. Female gender, older age, and IBS-diarrhea, but not PPI use, were associated with SIBO among individuals with IBS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Low fermentable oligosaccharide, disaccharide, monosaccharide and polyol (FODMAP) diets, a mainstay of IBS management, and small intestinal bacterial overgrowth (SIBO), a complication of IBS, are both related to alterations in the microbiota.”
From Association Between Sex Hormone Levels and Gut Microbiota Composition and Diversity—A Systematic Review (2022) · cites this paper as [47]
Citations
Cites
(2014) · Medical Entomology and Zoology · Cited by 17,633
Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis
Lovell, R. M., & Ford, A. C. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.02.029 · Cited by 2,155 · cited 1×
“affects more than a tenth of the general population [1, 2].”
(2012) · Hepatogastroenterology · doi:10.5754/hge12281 · Cited by 2,097
Eradication of Small Intestinal Bacterial Overgrowth Reduces Symptoms of Irritable Bowel Syndrome
Pimentel, M., Chow, E. J., & Lin, H. C. (2000) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.03368.x · Cited by 780
Biesiekierski, J. R., Newnham, E. D., Irving, P. M., Barrett, J. S., Haines, M., Doecke, J. D., Shepherd, S. J., Muir, J. G., & Gibson, P. R. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.487 · Cited by 717
Small intestinal bacterial overgrowth syndrome
Bures, J. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i24.2978 · Cited by 620 · cited 1×
“Although the gold standard for diagnosing SIBO is considered to be small intestinal fluid aspiration to quantify bacterial culture [9], other less-invasive Electronic supplementary material The online version of this article (https://doi.”
Small intestinal bacterial overgrowth in patients with irritable bowel syndrome
Posserud, I., Stotzer, P.-O., Björnsson, E. S., Abrahamsson, H., & Simrén, M. (2007) · Gut · doi:10.1136/gut.2006.108712 · Cited by 499 · cited 3×
“The reported prevalence of SIBO in the IBS population is highly variable, ranging from 4 to 84%, which may be related to the testing methods performed to diagnose SIBO [7, 11].”
Proton Pump Inhibitor Use and the Risk of Small Intestinal Bacterial Overgrowth: A Meta-analysis
Lo, W., & Chan, W. W. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.12.011 · Cited by 353 · cited 1×
“However, the risk of SIBO specifically among individuals with IBS is unclear [19, 76].”
Ford, A. C., Spiegel, B. M. R., Talley, N. J., & Moayyedi, P. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.06.031 · Cited by 351 · cited 2×
“Due to the potential inaccuracy of small studies, we excluded studies with less than eighty individuals as the previous meta-analysis [6].”
Increased Incidence of Small Intestinal Bacterial Overgrowth During Proton Pump Inhibitor Therapy
Lombardo, L., Foti, M., Ruggia, O., & Chiecchio, A. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.12.022 · Cited by 350 · cited 1×
“Four case–control studies containing 308 healthy controls and 661 IBS patients who had not used PPI prior to testing for SIBO were identified [23, 35, 37, 39].”
Research works printed but not linked: 4
- Philip A, Joseph V, Mukunda M, et al. Prevalence of small intestinal bacterial overgrowth in patients with irritable bowel syndrome using lactulose hydrogen breath test. Indian J Gastroenterol. 2013;32(1):A31.
- Qing Y. Relationship between the irritable bowel syndrome and small intestinal bacterial. J Gastroenterol Hepatol. 2013;28:375.
- Man F, Bustos Fernandez L, Bolino C. Prevalence of abnormal hydrogen excretion in non constipated irritable bowel syndrome patients. J Gastroenterol Hepatol. 2013;28:124.
- McCallum R, Schultz C, Sostarich S. Evaluating the role of small intestinal bacterial overgrowth (SIBO) in diarrhea predominant irritable bowel syndrome (IBS-D) patients utilizing the glucose breath test (GBT). Gastroenterology. 2005;128(4):A460.
Cited by
Kastl, A. J., Terry, N. A., Wu, G. D., & Albenberg, L. G. (2020) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.07.006 · Cited by 358
Advancing human gut microbiota research by considering gut transit time
Procházková, N., Falony, G., Dragsted, L. O., Licht, T. R., Raes, J., & Roager, H. M. (2023) · Gut · doi:10.1136/gutjnl-2022-328166 · Cited by 308
“183 SIBO is prevalent among patients with IBS, 184 a condition characterised by abdominal pain or discomfort and associated with changes in bowel habits affecting more than a tenth of the general population.”
BackgroundWang, L., Alammar, N., Singh, R., Nanavati, J., Song, Y., Chaudhary, R., & Mullin, G. E. (2020) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2019.05.015 · Cited by 209
Shah, A., Talley, N. J., Jones, M., Kendall, B. J., Koloski, N., Walker, M. M., Morrison, M., & Holtmann, G. J. (2020) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000504 · Cited by 200
Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome—An Update
Takakura, W., & Pimentel, M. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00664 · Cited by 148
“A positive H2 breath test is diagnostic of SIBO, which has been associated with diarrheapredominant IBS (IBS-D) and IBS with mixed bowel habits (IBSM) (10).”
BackgroundSmall and Large Intestine (I): Malabsorption of Nutrients
Montoro, M. A., Belloc, B., & Domínguez‐Cajal, M. (2021) · Nutrients · doi:10.3390/nu13041254 · Cited by 197
“Narcotic use, intestinal pseudo-obstruction, diabetes, and even irritable bowel syndrome [25,26], and other factors such as scleroderma lead to a lack of activity of phase III of the migrating motor complex, and a consequent failure to cleanse the small bowel.”
Backgroundd’Afflitto, M., Upadhyaya, A., Green, A., & Peiris, M. (2022) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001676 · Cited by 142
Losurdo, G., Leandro, G., Ierardi, E., Perri, F., Barone, M., Principi, M., & Leo, A. D. (2019) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm19113 · Cited by 135
Shah, A., Morrison, M., Burger, D. C., Martin, N., Rich, J., Jones, M., Koloski, N. A., Walker, M. M., Talley, N. J., & Holtmann, G. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15133 · Cited by 122
“However, the results have been conflicting with some finding a positive(67) and others finding a negative association.(68) In summary, this is the first systematic review and meta‐analyses, utilising the breath test as a diagnostic modality which demonstrates a”
ResultThe Spectrum of Small Intestinal Bacterial Overgrowth (SIBO)
Quigley, E. M. M. (2019) · Current Gastroenterology Reports · doi:10.1007/s11894-019-0671-z · Cited by 117
Thumann, T. A., Pferschy‐Wenzig, E., Moissl‐Eichinger, C., & Bauer, R. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112153 · Cited by 112
Epidemiology of small intestinal bacterial overgrowth
Efremova, I., Maslennikov, R. V., Poluektova, E. A., Vasilieva, E., Zharikov, Y. O., Suslov, A. V., Letyagina, Y., Kozlov, E. M., Levshina, A., & Ivashkin, V. T. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i22.3400 · Cited by 121
Small Intestinal Bacterial Overgrowth in Children: A State-Of-The-Art Review
Avelar Rodriguez, D., Ryan, P. M., Toro Monjaraz, E. M., Ramirez Mayans, J. A., & Quigley, E. M. (2019) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00363 · Cited by 91
Ghoshal, U. C., Sachdeva, S., Ghoshal, U., Misra, A., Puri, A. S., Pratap, N., Shah, A., Rahman, M. M., Gwee, K. A., Tan, V. P. Y., et al. (2022) · Indian Journal of Gastroenterology · doi:10.1007/s12664-022-01292-x · Cited by 109
Small Intestinal Bacterial Overgrowth in Functional Dyspepsia: A Systematic Review and Meta-Analysis
Gurusamy, S. R., Shah, A., Talley, N. J., Koloski, N. A., Jones, M. P., Walker, M. M., Morrison, M., & Holtmann, G. (2021) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001197 · Cited by 91
Zhang, Q., Zhong, D., Sun, R., Zhang, Y., Pegg, R. B., & Zhong, G. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.117418 · Cited by 89
Self-citationLayer, P., Andresen, V., Allescher, H., Bischoff, S. C., Claßen, M., Elsenbruch, S., Freitag, M., Frieling, T., Gebhard, M., Goebel-Stengel, M., et al. (2021) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1591-4794 · Cited by 76
Tansel, A., & Levinthal, D. J. (2023) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000567 · Cited by 89
“More than one-third of individuals with IBS test positive for SIBO (90).”
Kurdi, B. E., Babar, S., Iskandarani, M. E., Bataineh, A., Lerch, M. M., Young, M., & Singh, V. P. (2019) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000072 · Cited by 74
“SIBO is associated with inflammatory bowel disease (9,10), neurological disorders (11,12), celiac disease (13), and irritable bowel syndrome (14).”
BackgroundChey, W. D., Shah, E. D., & DuPont, H. L. (2020) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284819897531 · Cited by 62
How to Recognize and Treat Small Intestinal Bacterial Overgrowth?
Skrzydło-Radomańska, B., & Cukrowská, B. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11206017 · Cited by 55
“Therefore, our interdisciplinary research team attempted to assess the effects of single-strain probiotic preparations containing a Bifidobacterium lactis strain (NORDBIOTIC™ BI040) or a Bacillus coagulans strain (NORDBIOTIC™ BC300) on clinical symptoms and the concentration of hydrogen in a breath test in patients wi…”
BackgroundInfluentialGuidelines on the management of irritable bowel syndrome
Pietrzak, A., Skrzydło-Radomańska, B., Mulak, A., Lipiński, M., Małecka-Panas, E., Reguła, J., & Rydzewska, G. (2018) · Gastroenterology Review · doi:10.5114/pg.2018.78343 · Cited by 23
“Due to the frequent coexistence of SIBO in patients with IBS (especially in the diarrhoea-predominant form and with extensive bloating), breath testing for SIBO should be included in the diagnostics [30].”
BackgroundSundin, J., Aziz, I., Nordlander, S., Polster, A. V., Hu, Y. O. O., Hugerth, L. W., Pennhag, A. A. L., Engstrand, L. G., Törnblom, H., Simrén, M., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-57468-y · Cited by 57
Distinctive Clinical Correlates of Small Intestinal Bacterial Overgrowth with Methanogens
Madigan, K. E., Bundy, R. A., & Weinberg, R. B. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.09.035 · Cited by 46
Altered gut microbiota in patients with small intestinal bacterial overgrowth
Bamba, S., Imai, T., Sasaki, M., Ohno, M., Yoshida, S., Nishida, A., Takahashi, K., Inatomi, O., & Andoh, A. (2022) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16013 · Cited by 42
Gut-brain pathogenesis of post-acute COVID-19 neurocognitive symptoms
Plummer, A. M., Matos, Y. L., Lin, H. C., Ryman, S. G., Birg, A., Quinn, D. K., Parada, A. N., & Vakhtin, A. A. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1232480 · Cited by 41
“, 2017) indicates dysbiosis associated with diarrhea (Chen et al., 2018), while a positive CH4 result (>10 ppm over baseline) (Rezaie et al.”
Shah, A., Gurusamy, S. R., Hansen, T. J., Callaghan, G., Talley, N. J., Koloski, N. A., Walker, M. M., Jones, M. P., Morrison, M., & Holtmann, G. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-021-07149-1 · Cited by 39
Brenner, D. M., Harris, L. A., Chang, C. H., Waldman, S. A., Poppers, D. M., Kassebaum-Ladewski, A., & Sayuk, G. S. (2022) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001709 · Cited by 38
“The prevalence of SIBO in patients with IBS, based on ameta-analysis of 50 studies, is 38% (24).”
BackgroundWu, K., Sun, W., Li, N., Chen, Y., Wei, Y., & Chen, D. (2019) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2019.1694067 · Cited by 37
“Moreover, the occurrence of SIBO in IBS-D were nearly five-fold than healthy population [5].”
BackgroundResultInfluentialZhuang, X., Tian, Z., Luo, M., & Xiong, L. (2020) · BMC Gastroenterology · doi:10.1186/s12876-020-01336-6 · Cited by 32
Redondo‐Cuevas, L., Belloch, L., Martín-Carbonell, V., Nicolás, A., Alexandra, I., Artero, L. S., Ynfante, M., Colmenares, M., Mora, M., Liebana, A. R., et al. (2024) · Nutrients · doi:10.3390/nu16071083 · Cited by 36
“Our results show that, in general, SIBO is more frequent in women and the most common type of SIBO is CH 4 -SIBO, similar to what is reported in the literature [27–29].”
ResultYang, M. J., Zhang, L., Hong, G., Li, Y., Li, G., Qian, W., Xiong, H., Bai, T., Song, J., & Hou, X. (2019) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14910 · Cited by 31
The Role of Bacteria-Derived Hydrogen Sulfide in Multiple Axes of Disease
Birg, A., & Lin, H. C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073340 · Cited by 26
“While the pathogenesis of IBS is still controversial, there is an important role for gut dysbiosis as characterized by increased prevalence of abnormal breath test results in IBS [73].”
Abhari, K., Saadati, S., Oskouie, F. H., Yari, Z., Hosseini, H., Sohrab, G., Hejazi, E., Agah, S., Sadeghi, A., & Hekmatdoost, A. (2019) · European Journal of Nutrition · doi:10.1007/s00394-019-02060-y · Cited by 28
Clinical Management of the Microbiome in Irritable Bowel Syndrome
Andrews, C. N., Sidani, S., & Marshall, J. K. (2020) · Journal of the Canadian Association of Gastroenterology · doi:10.1093/jcag/gwz037 · Cited by 26
A Narrative Review of Irritable Bowel Syndrome with Diarrhea: A Primer for Primary Care Providers
Moshiree, B., Heidelbaugh, J. J., & Sayuk, G. S. (2022) · Advances in Therapy · doi:10.1007/s12325-022-02224-z · Cited by 34
“Prevalence of small intestinal bacterial overgrowth (SIBO) has been estimated at 38% in patients with IBS [48].”
BackgroundLow-FODMAP Diet for the Management of Irritable Bowel Syndrome in Remission of IBD
Więcek, M., Panufnik, P., Kaniewska, M. A., Lewandowski, K., & Rydzewska, G. M. (2022) · Nutrients · doi:10.3390/nu14214562 · Cited by 27
“This was much higher than the average proportion of SIBO in IBS in the general population, which varies from 14% to 40%, depending on the diagnostic method [8,10,21,22].”
BackgroundMethodGut microbiome associated dysbiosis: Limited regimens and expanding horizons of phage therapy
Singha, B., Rawat, B. S., Venkataraman, R., Nair, T., Rosenn, E. H., & Soni, V. (2023) · Aspects of Molecular Medicine · doi:10.1016/j.amolm.2023.100029 · Cited by 26
Gastrointestinal Microbiome and Multiple Health Outcomes: Umbrella Review
Chang, C., Yuan, X., Zhang, X., Chen, X., & Li, K. (2022) · Nutrients · doi:10.3390/nu14183726 · Cited by 24
Guo, H., Chen, Y., Dong, W., Lu, S., Du, Y., & Duan, L. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05316-2 · Cited by 19
Ng, J. J. J., Loo, W. M., & Siah, K. T. H. (2023) · World Journal of Hepatology · doi:10.4254/wjh.v15.i7.925 · Cited by 23
Belgian consensus on irritable bowel syndrome
Kindt, S., Louis, H., Schepper, H. U. D., Arts, J., Caenepeel, P., Looze, D. A. D., Gerkens, A., Holvoet, T., Latour, P., Mahler, T., et al. (2022) · Acta gastro-enterologica belgica · doi:10.51821/85.2.10100 · Cited by 26
Small Intestinal Bacterial and Fungal Overgrowth: Health Implications and Management Perspectives
Soliman, N., Kruithoff, C., Valentin, E. M. D. S., Gamal, A., McCormick, T. S., & Ghannoum, M. A. (2025) · Nutrients · doi:10.3390/nu17081365 · Cited by 30
“Some studies suggest females may be at higher risk of developing SIBO [24,43], while others indicate no association between SIBO and gender or race [43].”
Guo, H., Lu, S., Zhang, J., Chen, C., Du, Y., Wang, K., & Duan, L. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1121435 · Cited by 23
“Based on the similarity of the clinical manifestation profiles between IBS and SIBO, the prevalence of SIBO in IBS patients has been widely reported to range from 4% to 84%, with an overall pooled prevalence rate of 38% (Chen et al., 2018).”
BackgroundZhu, L., Xu, S., Guo, H., Lu, S., Gao, J., Hu, N., Chen, C., Liu, Z., Ji, X., Wang, K., et al. (2024) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2024-0009 · Cited by 16
Nutritional Approach to Small Intestinal Bacterial Overgrowth: A Narrative Review
Velasco-Aburto, S., Llama‐Palacios, A., Sánchez, M. C., Ciudad, M. J., & Yurrita, L. C. (2025) · Nutrients · doi:10.3390/nu17091410 · Cited by 19
“Highlighting the need for accurate diagnoses to ensure adequate treatment [6].”
Wanzl, J., Gröhl, K., Kafel, A. J., Nagl, S., Muzalyova, A., Gölder, S. K., Ebigbo, A., Messmann, H., & Schnoy, E. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12030935 · Cited by 19
“SIBO can be associated with a variety of different clinical conditions and is often found in patients with irritable bowel syndrome (IBS) [1].”
ResultInfluentialMareș, C. R., Săsăran, M. O., & Mărginean, C. O. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1431660 · Cited by 15
High Prevalence of Pathological Hydrogen Breath Tests in Patients with Functional Dyspepsia
Petzold, G., Amanzada, A., Gress, T. M., Ellenrieder, V., Neeße, A., & Kunsch, S. (2018) · Digestion · doi:10.1159/000494718 · Cited by 11
Irritable bowel syndrome in midlife women: a narrative review
Yang, P.-L., Heitkemper, M. M., & Kamp, K. (2021) · Women s Midlife Health · doi:10.1186/s40695-021-00064-5 · Cited by 16
“A number of factors including differences in pain sensitivity due to both peripheral and central processing mechanisms, co-morbid psychological distress, small intestinal bacterial overgrowth, and motility contribute to this sex difference [9].”
BackgroundTseng, P., Chiu, H., Tu, C., Wu, M., Ho, H., & Chen, M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.779456 · Cited by 15
Kucheryavyy, Y. A., Андреев, Д. Н., & Maev, I. V. (2020) · Terapevticheskii arkhiv · doi:10.26442/00403660.2020.12.200433 · Cited by 12
“Полученные в настоящем метаанализе данные достаточно близки к результатам последних метаанализов, анализировавших распространенность СИБР у пациентов с СРК и продемонстрировавших частоту от 35,5 до 38% [11, 12].”
Xiong, Y., Liu, L., Zhou, X., Wen, Y., & Wang, R. (2020) · Clinics · doi:10.6061/clinics/2020/e1857 · Cited by 10
“Female sex, higher age, and IBS-induced diarrhea were all associated with SIBO in individuals with IBS (28).”
BackgroundLee, J. Y., Paik, C. N., Kim, D. B., Lee, J. M., Kim, Y., Choi, S. K., & Cho, Y. J. (2022) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm20231 · Cited by 8
“There are still controversy to usefulness for breath tests to reflect SIBO in patients with FGID.(20,21) In addition, most proposed guidelines(22,23) for breath tests are based on research for adults, and thus it is unclear whether this proposal will also apply to children.”
BackgroundLoo, Q. Y., Chuah, K. H., Hian, W. X., Khoo, X. H., Lee, Y. Y., & Mahadeva, S. (2025) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16891 · Cited by 8
Ye, Y., Liu, Y., Cheng, K., Wu, Z., Zhang, P., & Zhang, X. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.810453 · Cited by 8
Salas, A., Yanek, L. R., Hummers, L. K., Shah, A. A., & McMahan, Z. H. (2025) · ACR Open Rheumatology · doi:10.1002/acr2.11796 · Cited by 8
“38,39 However, concomitant PPI use, which also increases patients ’ risk for SIBO, may confound this association.”
Vernia, P., Cesarini, M., de Carolis, A., & Vernia, F. (2020) · Digestive and Liver Disease · doi:10.1016/j.dld.2020.07.035 · Cited by 7
Bouveret's syndrome and digestive endoscopy as diagnostic support
Martínez, A. G., Millán, D. M., Prado, Á. M., & García, J. P. (2024) · Revista Andaluza de Patología Digestiva · doi:10.37352/2024471.4 · Cited by 5
Introduction to the Gut Microbiome and Its Impact on Health and Disease
Comess, J. E., & Abad-Jorge, A. (2023) · Topics in Clinical Nutrition · doi:10.1097/tin.0000000000000324 · Cited by 8
Mechanisms and pathophysiology leading to development of small intestinal microbial dysbiosis
Damianos, J., Wang, X. J., & Camilleri, M. (2026) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(25)00295-x · Cited by 8
Chinese Herbal Medicine for Irritable Bowel Syndrome: A Perspective of Local Immune Actions
Zhang, M., Wu, X., Gao, H.-Q., Zhang, L., Li, Y., Li, M., Zhao, C., Wei, P., & Li, O. (2024) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x24500800 · Cited by 6
Management of Sleep and Fatigue in Gastrointestinal Patients
Salwen‐Deremer, J. K., & Sun, M. (2022) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2022.07.007 · Cited by 6
Владимирович, И. К., Grechishnikova, V. R., Reshetova, M. S., & Ivashkin, V. T. (2021) · Russian Journal of Gastroenterology Hepatology Coloproctology · doi:10.22416/1382-4376-2021-31-1-54-63 · Cited by 4
“50 исследований и 8398 пациентов с СРК [34]:”
The modern ideas about the etiology of irritable bowel syndrome
Сахаутдинова, Г. М., Nagaeva, R. R., & Asanbaeva, K. E. (2019) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2019-3-152-155 · Cited by 5
Influencing Factors on Lactulose Breath Test Results
Kim, J. W., Park, S., Chung, J. O., Cho, H. A., Kim, D. H., Yoon, J. H., Park, C., Kim, H., Choi, S. K., & Rew, J. S. (2020) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2020.75.1.23 · Cited by 4
Self-citationKim, D. B., Park, C., Paik, C. N., Kang, Y. J., Jo, I. H., & Lee, J. M. (2022) · Saudi Journal of Gastroenterology · doi:10.4103/sjg.sjg_134_22 · Cited by 3
“Saudi Journal of Gastroenterology | Volume 28 | Issue 5 | September-October 2022 359 cause of SIBO.[20,21] Therefore, it can be cautiously inferred that SIBO is associated with sleep disorders.”
BackgroundInfluentialDervin, H., Zárate-López, N., Sweis, R., Mensah, A., Fragkos, K. C., Brugaletta, C., Raeburn, A. J., & Emmanuel, A. V. (2023) · Neurogastroenterology & Motility · doi:10.1111/nmo.14570 · Cited by 8
Common questions and rationale answers about the intestinal bacterial overgrowth syndrome (SIBO)
González, J. A., Estremera, F., Cobián, J., Santos, J., Alcala-Gonzalez, L. G., Naves, J., Barba, E., Barber, C., Falcón, B. S., Accarino, A. M., et al. (2024) · Gastroenterología y Hepatología (English Edition) · doi:10.1016/j.gastre.2024.502216 · Cited by 4
Intestinal dysfunction in chronic disease
Kirschner, S. K., Deutz, N. E. P., & ENGELEN, M. P. K. J. (2021) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000780 · Cited by 4
“However, these studies lack the inclusion of healthy control groups, which appears essential because the methods and the definitions used to diagnose SIBO induce a variability of the reported prevalences between different studies [38].”
BackgroundHomemade Elemental Diet to Treat Intestinal Methanogen Overgrowth: A Case Report.
O'Dwyer, D. D. (2021) · PubMed Central · Cited by 3
Small Intestinal Bacterial Overgrowth
Rodriguez, D. A., Ryan, P. M., & Quigley, E. M. M. (2021) · Springer eBooks · doi:10.1007/978-3-030-80068-0_42 · Cited by 4
Small Intestinal Bacterial Overgrowth Syndrome
Dharmarajan, T. S., & Pitchumoni, C. S. (2021) · Springer eBooks · doi:10.1007/978-3-030-30192-7_62 · Cited by 3
Chang, H.-C., Hsu, Y., Chen, S., WU, M.-C., & Gau, S.-Y. (2026) · Scientific Reports · doi:10.1038/s41598-026-38442-6 · Cited by 2
“Similarly, patients with IBS often exhibit gut microbial imbalance or small intestinal bacterial overgrowth (SIBO), which contributes to mucosal immune activation and gastrointestinal symptoms 24,25 .”
SIBO – what the general practitioner should know
Ostrowski, B., & Kukla, M. (2020) · Pediatria i Medycyna Rodzinna · doi:10.15557/pimr.2020.0009 · Cited by 3
“The risk of SIBO in this group is approximately five times higher than in the control group (27) , and the disorders are often found to coexist.”
Yiğit, A., & Samur, G. (2022) · Current Nutrition & Food Science · doi:10.2174/1573401318666220520100202 · Cited by 2
Hsu, Y., Yang, H., Huang, W., Chen, S. C., & Lee, H. (2019) · PLoS ONE · doi:10.1371/journal.pone.0220641 · Cited by 3
Irritable bowel syndrome and gut microbiota
Jacenik, D., & Zielińska, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-821324-7.00005-8 · Cited by 2
Restrictive diet in a patient with irritable bowel syndrome leading to Wernicke encephalopathy
Wang, Q., Charmchi, Z., & George, I. C. (2021) · BMC Gastroenterology · doi:10.1186/s12876-021-01758-w · Cited by 2
An ingestible device for automated sampling and location tracing in gastrointestinal tract
Li, T., Felton, J. A., Lewis, J., Cheng, Q., Meredith, R., Lu, H.-T., Benken, A. C., Dutta, P. P., Liao, J., Zhao, X., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0327667 · Cited by 2
“…be indicators of cancer [3,4], bacterial infections (e.g., H pylori [5,6] and C. difficile [7]), ulcer [8], GI bleeding [9], bacteria overgrowth [10], etc. Traditional sampling methods rely upon intubation using catheters [1,2] that have specially designed openings to collect fluids from…”
Choudhary, A. K., Hait, A., Ganesan, S., Howlader, S., & Periasamy, P. (2026) · The Egyptian Journal of Internal Medicine · doi:10.1186/s43162-026-00646-7 · Cited by 3
Cybulska, A. M. (2019) · Pediatria i Medycyna Rodzinna · doi:10.15557/pimr.2019.0043
“Rifaximin has immunomodulatory activity (stimulation of anti-inflammatory and inhibition of proinflammatory cytokines), reduces the pathological permeability of enterocytes and restores the tightness of intestinal barrier (17,61) .”
Andersson, O. P. (2023) · International Journal of Colorectal Disease · doi:10.1007/s00384-023-04406-9 · Cited by 3
“Interestingly, a meta-analysis by Chen et al. [66] found that SIBO presents a fivefold risk of receiving an IBS diagnosis compared to controls, along with more than a third of IBS patients in the samples tested positive for SIBO.”
The role of probiotics in current algorithms for the treatment of irritable bowel syndrome: A review
Андреев, Д. Н., & Maev, I. V. (2023) · Consilium Medicum · doi:10.26442/20751753.2023.5.202131 · Cited by 1
“), обобщивший результаты 50 исследований (8398 пациентов с СРК, 1432 лица контроля), подтвердил, что СИБР многократно чаще выявляется у больных с СРК (отношение шансов – ОШ 4,7, 95% ДИ 3,1–7,2) [22].”
González, J. A., Estremera, F., Cobián, J., Santos, J., Alcala-Gonzalez, L. G., Naves, J., Barba, E., Barber, C., Falcón, B. S., Accarino, A. M., et al. (2024) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2024.502216 · Cited by 5
The role of in the development of small intestinal bacterial overgrowth syndrome
Kolmogorova, T. O., & Anchikova, T. A. (2019) · Russian Journal of Evidence-Based Gastroenterology · doi:10.17116/dokgastro2019803112 · Cited by 1
Kurniawan, A. H., Gunawan, V. A., Suwandi, B. H., & Kholili, U. (2020) · The Indonesian Journal of Gastroenterology Hepatology and Digestive Endoscopy · doi:10.24871/211202038-44 · Cited by 1
Dysbiosis, Small Intestinal Bacterial Overgrowth, and Chronic Diseases: A Translational Approach
Silva, A. R., Bernardo, A., de Mesquita, M. F., Patto, J. V., Moreira, P. A. M., Padrão, P., & Silva, M. L. (2020) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-7998-4808-0.ch015 · Cited by 4
Kucheryavy, Y. A., & Andreyev, D. N. (2020) · Effective Pharmacotherapy · doi:10.33978/2307-3586-2020-16-24-40-44 · Cited by 2
Small Intestinal Bacterial Overgrowth Syndrome
Dharmarajan, T. S., & Pitchumoni, C. S. (2020) · Springer eBooks · doi:10.1007/978-3-319-90761-1_62-1 · Cited by 1
Haubensak, R. (2018) · Lincoln (University of Nebraska)
Schindler, V., Huellner, M. W., Murray, F. R., Schnurre, L., Becker, A. S., Bordier, V., & Pohl, D. (2020) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm19162
Janelidze, D. T. (2020) · GASTROENTEROLOGY · doi:10.22141/2308-2097.54.4.2020.216843
Schmulson, M. J., & Saps, M. (2018) · NeuroGastroLATAM Reviews · doi:10.24875/ngl.m18000009
Irritable bowel syndrome – modern ways of treatment
Kuciński, J., Fryska, Z., Wołejko, A., KULIK, K., Semeniuk, P., Matusz, K., Burczyk, R., & Górna, N. (2023) · Journal of Education Health and Sport · doi:10.12775/jehs.2023.16.01.005 · Cited by 1
罗, 绪. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.1381893
Guo, H., Chen, Y., Dong, W., Lu, S., Du, Y., & Duan, L. (2024) · Research Square · doi:10.21203/rs.3.rs-3823305/v1
The Role of Gut Bacteria in Functional Gastrointestinal Disorders
Damianos, J., & Shah, E. D. (2023) · Springer eBooks · doi:10.1007/978-3-031-46712-7_6
Alcohol use disorder. The other disease.
Lara, M. L., Gea, A. V., & Martínez, M. (2024) · Revista Andaluza de Patología Digestiva · doi:10.37352/2024471.3
Metadata
- Authors
- Chen, B., Kim, J. J.-W., Zhang, Y., Du, L., & Dai, N.
- Affiliations
- Sir Run Run Shaw Hospital (CN)
- Loma Linda University Medical Center (US)
- Corresponding author
- Dai, Ning
- Venue
- Journal of Gastroenterology
- Published
- 2018-05-14
- Volume
- 53
- Issue
- 7
- Pages
- 807-818
- ISSN
- 0944-1174 (ISSN-L)
- 1435-5922
- OpenAlex
- W2802465698
- Cited by
- 117
- References
- 75
- Citations by year
- 2026: 8 · 2025: 7 · 2024: 21 · 2023: 14 · 2022: 16 · 2021: 13 · 2020: 18 · 2019: 16 · 2018: 4
- FWCI
- 2.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81670487)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Helicobacter pylori-related gastroenterology studies
- Keywords
- small intestinal bacterial overgrowth, irritable bowel syndrome, prevalence, risk factors, breath test, culture diagnosis, proton pump inhibitors, female sex, old age
- MeSH terms
- Adult, Age Factors, Bacterial Infections, Breath Tests, Diarrhea, Female, Humans, Intestine, Small, Male, Middle Aged, Sex Factors, Prevalence, Irritable Bowel Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.